As on Wednesday, Viking Therapeutics Inc (NASDAQ: VKTX) got off with the flyer as it spiked 3.03% to $31.63, before settling in for the price of $30.7 at the close. Taking a more long-term approach, VKTX posted a 52-week range of $18.92-$81.73.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -23.00%. Meanwhile, its Annual Earning per share during the time was -23.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -86.96%. This publicly-traded company’s shares outstanding now amounts to $112.29 million, simultaneously with a float of $108.96 million. The organization now has a market capitalization sitting at $3.55 billion. At the time of writing, stock’s 50-day Moving Average stood at $27.86, while the 200-day Moving Average is $38.46.
Viking Therapeutics Inc (VKTX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Viking Therapeutics Inc’s current insider ownership accounts for 2.98%, in contrast to 69.39% institutional ownership. According to the most recent insider trade that took place on Jul 03 ’25, this organization’s President & CEO sold 26,889 shares at the rate of 27.80, making the entire transaction reach 747,633 in total value, affecting insider ownership by 2,388,014. Preceding that transaction, on Jul 03 ’25, Company’s Chief Financial Officer sold 4,266 for 27.76, making the whole transaction’s value amount to 118,428. This particular insider is now the holder of 168,660 in total.
Viking Therapeutics Inc (VKTX) Earnings and Revenue Records
Viking Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -86.96% and is forecasted to reach -2.57 in the upcoming year.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Let’s observe the current performance indicators for Viking Therapeutics Inc (VKTX). It’s Quick Ratio in the last reported quarter now stands at 44.25.
In the same vein, VKTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.15, a figure that is expected to reach -0.45 in the next quarter, and analysts are predicting that it will be -2.57 at the market close of one year from today.
Technical Analysis of Viking Therapeutics Inc (VKTX)
Through scrutinizing the latest numbers posted by the [Viking Therapeutics Inc, VKTX], it can be observed that its last 5-days Average volume of 2.93 million was lower the volume of 4.1 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 85.92% While, its Average True Range was 67.68%.
Raw Stochastic average of Viking Therapeutics Inc (VKTX) in the period of the previous 100 days is set at 72.75%, which indicates a major fall in contrast to 92.54% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.64 that was lower than 1.82 volatility it exhibited in the past 100-days period.
